Nov 25 (Reuters) - Eton Pharmaceuticals Inc ( ETON ):
* ETON PHARMACEUTICALS ANNOUNCES ACQUISITION OF U.S. RIGHTS
TO
AMGLIDIA (GLYBURIDE ORAL SUSPENSION)
* ETON PHARMACEUTICALS INC ( ETON ) - PLANS FDA MEETING IN Q1 2025,
NDA
SUBMISSION IN 2026
Source text:
Further company coverage: